Breaking News

Vectura Expands Dry Powder Inhaler Capabilities

Bolsters development and manufacturing capabilities at its facility in Chippenham, U.K.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vectura Group, an inhalation contract development and manufacturing organization (CDMO), has expanded its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K.   Investment has been made at the site to install a new capsule filler, a capsule blister packer, and a Mikron semi-automated device assembly machine. These enhancements will support work with capsule inhaler devices, Vectura’s open inhale close (OIC) device and the lever-operated multi-do...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters